Investigating how a specific gene modification affects the survival of mosquitoes in extreme climates

The role of H3K27me2 in regulating Culex pipiens diapause

NIH-funded research Baylor University · NIH-10579546

This study is looking at how a specific gene change helps northern house mosquitoes survive tough weather by allowing them to rest and store energy, and it's for anyone interested in understanding how these mosquitoes adapt to their environment.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionBaylor University NIH-funded
Lab location1 site (Waco, United States)
Project IDNIH-10579546 on NIH RePORTER

What this research studies

This research focuses on understanding how a gene modification known as H3K27me2 influences the ability of the northern house mosquito, Culex pipiens, to survive harsh environmental conditions through a process called diapause. The researchers will explore the genetic mechanisms that allow these mosquitoes to extend their lifespan, store fat, and resist stress during extreme weather. By using advanced techniques like RNA sequencing and biochemical assays, they aim to identify key genes and pathways involved in these survival traits.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals interested in vector control and the ecological impacts of climate change on disease-carrying insects.

Not a fit: Patients who are not concerned with vector-borne diseases or the ecological aspects of mosquito survival may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for managing mosquito populations and controlling diseases they transmit.

How similar studies have performed: While the specific focus on H3K27me2 in mosquitoes is novel, similar genetic studies in other insects have shown promising results in understanding survival mechanisms.

Where this research is happening

Waco, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Disease Vectors
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.